Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Apr 23, 2010


Vermillion this week announced the appointment of Sandra Gardiner as vice president and chief financial officer.

Gardiner was previously at Bend Research where she was CFO and a member of its board. From 2004 to 2008, Gardiner was CFO and corporate secretary of Lipid Sciences.

In a document filed with the US Securities and Exchange Commission, Vermillion said her annual base salary will be at least $240,000. Gardiner will also be eligible for a bonus of up to 40 percent of her salary based on performance goals to be determined by the CEO or Vermillion's board.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.